The aim of the study was to determine whether the measurement of serum MMP-3 is clinically useful for assessing ongoing liver fibrosis in patients with PBC and assess whether an increased MMP-3 concentration may be associated with biochemical parameters, primarily with the level of bilirubin, and presence of specific antibodies. Here, MMP3 is linked to primary biliary cholangitis.